Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
FASEB J ; 16(13): 1823-5, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12354693

ABSTRACT

Induction of tumor cell migration is a key step in invasion and metastasis. Here we report that the epidermal growth factor (EGF)-induced cell migration of breast cancer cells is attributed to a transient, rather than a sustained, activation of phospholipase C (PLC)-gamma1 due to c-erbB-2 signaling. EGF stimulation of EGF receptor (EGFR) overexpressing cells resulted in long-term PLC-gamma1 tyrosine phosphorylation and sustained levels of inositol-1,4,5-triphosphate (IP3) and diacylglycerol (DAG) producing sinusoidal calcium oscillations. In contrast, c-erbB-2/EGFR expressing cells displayed baseline transient calcium oscillations after EGF treatment due to short-term PLC-gamma1 tyrosine phosphorylation and short-term IP3 and DAG turnover. A third cell line expressing a point-mutated c-erbB-2 receptor that lacks the autophosphorylation Y1248 was generated to investigate whether the different PLC-gamma1 activation was attributed to this structure. Neither PLC-gamma1 tyrosine phosphorylation nor IP3 and DAG turnover and calcium oscillations were observed in this cell line, indicating the modulation of the PLC-g1 activation time course by c-erbB-2 signaling. Induction of cell migration was solely observable in the c-erbB-2-positive cell line as proved by the mode of actin reorganization and a cell migration assay, using a 3D-collagen lattice. In summary, c-erbB-2 up-regulation switches on the cell migration program by modulating the time course of PLC-gamma1 activation.


Subject(s)
Cell Movement/drug effects , Epidermal Growth Factor/pharmacology , ErbB Receptors/metabolism , Receptor, ErbB-2/metabolism , Calcium/metabolism , Dimerization , Enzyme Activation/drug effects , ErbB Receptors/chemistry , Estrenes/pharmacology , Humans , Isoenzymes/antagonists & inhibitors , Isoenzymes/metabolism , Phosphodiesterase Inhibitors/pharmacology , Phospholipase C gamma , Phosphorylation/drug effects , Pyrrolidinones/pharmacology , Receptor, ErbB-2/chemistry , Signal Transduction , Tumor Cells, Cultured , Type C Phospholipases/antagonists & inhibitors , Type C Phospholipases/metabolism , Tyrosine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...